openPR Logo
Press release

Acquired Cystic Kidney Disease Treatment Market Soaring Demand Assures Motivated Revenue Share during 2018-2028

11-16-2018 08:57 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Acquired Cystic Kidney Disease Treatment Market Soaring Demand

Many people with chronic kidney diseases develop acquired cystic kidney disease, which is a condition in which the kidney has fluid-filled sacs known as cysts. Acquired cystic kidney disease occurs both, in adults and children. Acquired cystic kidney disease is more likely to develop in patients who are undergoing hemodialysis or peritoneal dialysis. Failure of the kidney causes acquired cystic kidney disease, and not the dialysis. The risk of developing acquired cystic kidney disease usually increases with the number of years an individual is on dialysis. Acquired cystic kidney disease occurs due to chronic renal failure, and the patient does not experience any symptoms. Acquired cystic kidney disease is mainly caused by the waste products which build up in the kidney due to poor filtration. According to the National Institute of Diabetes and Digestive and Kidney Disease, 7 to 22% of people with acquired cystic kidney disease have the disease before dialysis, and almost 60% of people on dialysis for 2 to 4 years develop acquired cystic kidney disease. Around 90% of people on dialysis for 8 years develop acquired cystic kidney disease.

Acquired Cystic Kidney Disease Treatment Market: Drivers and Restraints

The increasing instances of chronic kidney failure which ultimately leads to acquired cystic kidney disease, drives the market for acquired cystic kidney disease treatment, globally. Increasing awareness and development in novel treatments spur the market for acquired cystic kidney disease treatment. Increasing geriatric population and increasing healthcare expenditure drive the market for acquired cystic kidney disease treatment. Increased research and development activities for the treatment of acquired cystic kidney disease by major key players spur the market for acquired cystic kidney disease treatment. Increasing prevalence of diabetes which results in kidney failure boosts the market for acquired cystic kidney disease treatment.

Lack of specific treatment and shortage of skilled physicians and stringent regulations restrain the growth of the acquired cystic kidney disease treatment market.

Click here to subscribe Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1687 

Acquired Cystic Kidney Disease Treatment Market: Segmentation

Tentatively, the global acquired cystic kidney disease treatment market can be segmented on the basis of treatment type, distribution channel, and geography.

Based on treatment type, the global acquired cystic kidney disease treatment market is segmented as:

Antibiotics
Non-steroidal Anti-inflammatory Medications
Others
Based on distribution channel, the global acquired cystic kidney disease treatment market is segmented as:

Hospital Pharmacies
Drug Stores
Retail Pharmacies
Others
Acquired Cystic Kidney Disease Treatment Market: Overview

The development of various techniques, increasing number of patients going for dialysis, and favorable reimbursement policies and government initiatives propel the growth of the acquired cystic kidney disease treatment market. On the basis of treatment type, the antibiotics segment accounts for the largest revenue share, owing to increased prescriptions by physicians for the treatment of acquired cystic kidney disease. On the basis of end user, the hospital pharmacies segment accounts for the anticipated growth during the forecast period, owing to the increasing prevalence of chronic kidney diseases and increasing number of dialysis in patients.

Acquired Cystic Kidney Disease Treatment Market: Regional Outlook

Geographically, the global acquired cystic kidney disease treatment market is segmented into North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the leading market in the global acquired cystic kidney disease treatment market, owing to increasing number of chronic kidney cases and increasing number of surgical procedures for acquired cystic kidney disease. The increasing demand for new techniques for the diagnosis of chronic kidney diseases drives the North American acquired cystic kidney disease treatment market. The acquired cystic kidney disease treatment market in Europe is the second-largest, due to improved infrastructure, increasing awareness of chronic kidney diseases, and increasing healthcare expenditure. The Asia Pacific excluding Japan market is expected to witness fast growth as compared to other regions, due to the large patient population, growing medical tourism, and favorable reimbursement policies. Japan accounts for moderate growth in the acquired cystic kidney disease treatment market, owing to the increasing geriatric population which increasing chronic kidney diseases. Latin America & Middle East & Africa are expected to account for slow growth during the forecast period, owing to slow diagnosis rates and poor healthcare facilities.

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=1687 

Acquired Cystic Kidney Disease Treatment Market: Key Players

The global acquired cystic kidney disease treatment market is highly fragmented, owing to the presence of a large number of manufacturers. Examples of some of the key players operating in the global acquired cystic kidney disease treatment market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., Johnson & Johnson Services, Inc. CordenPharma International, Pfizer Limited. Sanofi, Merck & Co., Inc., Allergan, and Baxter International, among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers an exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved
Technology
Value Chain
Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, Chile, Peru, and Rest of Latin America)
Europe [EU -4 (Germany, France, Italy, Spain), BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
CIS & Russia
Japan
APEJ (Greater China, India, S. Korea, ASEAN Countries and Rest of APEJ)
Middle East & Africa (GCC Countries, Turkey, Iran, Israel, South Africa, Rest of MEA)
Report Highlights:

A detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Report Analysis@ https://www.factmr.com/report/1687/acquired-cystic-kidney-disease-treatment-market 

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow us in Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acquired Cystic Kidney Disease Treatment Market Soaring Demand Assures Motivated Revenue Share during 2018-2028 here

News-ID: 1376004 • Views: 198

More Releases from Fact.MR

07-02-2020 | Health & Medicine
Fact.MR
Medical Device Contract Manufacturing Market Set for Strong Growth, Production F …
The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated
06-02-2020 | Health & Medicine
Fact.MR
Fluid Management Market Expected to Grow Amid Covid-19, Finds Fact.MR
Growing prevalence of chronic disease and an expansion in numbers of geriatric population is leading to an upward facing growth curve for global fluid management market over the period of 2020 to 2025, states Fact.MR. It projects a compound annual growth rate or CAGR of about 5.3% for the market over this period, helping the market push its worth up significantly. It is significant to note here that while number of
Hand Sanitizer Market to Surpass US$ 2.8 Bn, Instant Hand Sanitizer Poised to Ho …
The global hand sanitizer market is set to surpass a value of ~US$ 1.4 Bn in 2020 and is anticipated to cross US$ ~2.8 Bn during the forecast period 2020-2030. The demand for gel-based sanitizer is on the rise as compared to foaming or spray sanitizer. Thus, manufacturers are focusing on developing gel-based sanitizers as they are widely used in multiple end-use industries. With the increased penetration of the online
03-20-2020 | Health & Medicine
Fact.MR
Medical Marker Bands Market Grows on the back of Their Radiopacity and Cost-effe …
Radiopacity of medical marker bands is giving significant impetus to their demand in the medical marker bands market. The properties of medical marker bands that increases their visibility under fluoroscopes or x-ray during critical procedures is giving an uptick to their sales worldwide. Manufacturers of medical marker bands are also showing a marked preference for cost-effective materials such as polymer and tantalum instead of traditional gold, platinum and palladium. On

All 5 Releases


More Releases for Acquired

Global Acquired Aplastic Anemia Market Insights, Forecast
Acquired aplastic anemia is a rare, serious blood disorder, due to failure of the bone marrow failure to produce blood cells. Bone marrow is the spongy substance found in the center of the bones of the body, in adults mainly the spine, pelvis, and large bones of the legs. The global Acquired Aplastic Anemia market is valued at xx million US$ in 2018 and will reach xx million US$ by
Hospital Acquired Disease Testing - Evolving Market Trends
Global Hospital Acquired Disease Testing Market Insights  The rising incidence of hospital acquired infections (HAIs) has emerged as a major concern for governments, particularly across developing and underdeveloped countries. In first world countries such as the U.S., various regulations are in place for penalizing hospitals exhibiting a high incidence of HAIs. Such regulations augur well for the hospital acquired disease testing market in developed countries. In contrast, the absence of proper
CAROLINA UNDERGROUND SOLUTIONS ACQUIRED
Entrepreneur and Greenville Businessman, Braddock Cunningham, Acquires Carolina Underground Solutions Greenville, SC (May 30, 2017) – [CAROLINA UNDERGROUND SOLUTIONS] CUS, a leading underground telecommunications cabling and conduit contractor, today announced that they have been acquired by Braddock Cunningham, former CEO of Network Controls and Electric, where he grew his company to a South Carolina top 25 fastest growing company 4 times between 2008 and 2013. Cunningham who holds a
Noliac acquired by CTS Corporation
As of May 15th 2017, Noliac A/S has been acquired by CTS Corporation. Below is CTS' press release in this regard. CTS Acquires European Piezoelectric Sensor & Component Manufacturer Lisle, Ill. – CTS Corporation (NYSE: CTS) has announced the acquisition of Noliac A/S; a designer and manufacturer of tape cast and bulk piezoelectric components, sensors and transducers. Headquartered in Denmark with manufacturing facilities in Denmark and the Czech Republic, Noliac serves OEMs
Systech Illinois acquired by Union Park Capital
We are pleased to announce that Industrial Physics, Inc., a Boston-based test and measurement manufacturer and portfolio company of Union Park Capital have acquired Systech Illinois. Systech Illinois' application and technology expertise provides efficient gas analysis solutions in many industry sectors worldwide will be joined with TM Electronics in the Industrial Technology Group, as an independent operating entity under Industrial Physics. By combining resources the new formation will bring
Scribendi Inc. Acquired by MAGNUM Capital
MAGNUM Capital Partners ("MAGNUM"), a private investment firm led by Patricia Riopel and Enrico Magnani, has acquired online editing and proofreading company Scribendi Inc. ("Scribendi"). This acquisition is a strategic entry for MAGNUM into a growing industry with worldwide growth potential. English is an official language in more than 70 countries, representing a population of 2.9 billion people; people need to be able to communicate with each other clearly and quickly,